Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Read More Pharma Industry News China just sided with Novo Nordisk—here’s why this Wegovy patent ruling matters worldwide China’s top court just backed Novo Nordisk’s semaglutide patent—find out what this means for Wegovy and obesity drug rivals in 2026 and beyond. byVenkateshDecember 31, 2025